(Q34442832)

2 August 2017

1 reference

title

A roadmap to the brittle bones of cystic fibrosis (English)

1 reference

2 August 2017

0 references

Ashwini P Gore

1

1 reference

2 August 2017

Soon Ho Kwon

series ordinal

2

1 reference

2 August 2017

Antine E Stenbit

series ordinal

3

1 reference

2 August 2017

publication date

16 December 2010

1 reference

2 August 2017

published in

Journal of Osteoporosis

1 reference

2 August 2017

volume

2011

1 reference

2 August 2017

page(s)

926045

1 reference

Creative Commons Attribution 3.0 Unported

2 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Vitamin d deficiency in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Update on cystic fibrosis-related bone disease: a special focus on children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Potential new drug targets for osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Hyperinflammation in airways of cystic fibrosis patients: what's new?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

A soluble activin type IIA receptor induces bone formation and improves skeletal integrity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercise for bone health in children with cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

In vivo analysis of Wnt signaling in bone

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Update on maintaining bone health in cystic fibrosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Regulation of bone mass by Wnt signaling

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

BMD and body composition in children and young patients affected by cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone mineral density in sclerosteosis; affected individuals and gene carriers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Growth hormone improves bone mineral content in children with cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

A retrospective study of growth hormone use in adolescents with cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Oral antiresorptive therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Guide to bone health and disease in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

A school-based exercise intervention elicits substantial bone health benefits: a 2-year randomized controlled trial in girls

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone morphogenetic proteins, their antagonists, and the skeleton

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

A review of nutritional problems and the cystic fibrosis lung transplant patient.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Lung transplantation: management and complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Normal bone mineral density in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Advances in the recognition and treatment of endocrine complications in children with chronic illness.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Osteoporosis: a new challenge in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone mineral status in 134 patients with cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Musculoskeletal involvement in cystic fibrosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

The diagnosis of cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone mineral density and body composition in adult patients with cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Anabolic actions of parathyroid hormone on bone

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Kyphosis and fractures in children and young adults with cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Exercise in the management and rehabilitation of selected chronic diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.

6 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Osteopenia in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Alteration of bone mineral density in cystic fibrosis adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Prevalence of bone loss in a population with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Decreased bone mineral density in normal-growing patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Role of exercise and nutrition status on bone mineral density in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Calcium kinetics are altered in clinically stable girls with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Inhaled corticosteroids and hip fracture: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Steroid withdrawal in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Use of inhaled corticosteroids and risk of fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Lung transplantation for cystic fibrosis: 6-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunte

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F926045

Multiple vertebral compression fractures in a patient treated with corticosteroids for cystic fibrosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Mechanisms of insulin resistance in cystic fibrosis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010683

Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass

27 October 2018

1 reference

12 December 2020

Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid

1 reference

12 December 2020

Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis

1 reference

12 December 2020

Hip fracture and bone histomorphometry in a young adult with cystic fibrosis

1 reference

12 December 2020

Managing complications following lung transplantation

1 reference

12 December 2020

Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease

1 reference

12 December 2020

Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial

1 reference

12 December 2020

The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis

1 reference

12 December 2020

Bone mineral content and body composition in children and young adults with cystic fibrosis

1 reference

12 December 2020

Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis

1 reference

12 December 2020

Carboxylated Osteocalcin Levels in Cystic Fibrosis

1 reference

12 December 2020

Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study

1 reference

12 December 2020

Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis

1 reference

12 December 2020

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

1 reference

12 December 2020

Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis

1 reference

12 December 2020

Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation

1 reference

12 December 2020

Salivary testosterone levels in male adolescents with cystic fibrosis

1 reference

12 December 2020

Osteoporosis in juvenile-onset diabetes mellitus: morphometric and comparative studies

1 reference

12 December 2020

Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study.

1 reference

12 December 2020

Severe osteoporosis before and after lung transplantation

1 reference

12 December 2020

Bone density in children and adolescents with cystic fibrosis

1 reference

12 December 2020

Bone histomorphometry in adult patients with cystic fibrosis

1 reference

12 December 2020

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

1 reference

12 December 2020

Growth hormone normalizes pubertal onset in children with cystic fibrosis

1 reference

12 December 2020

New developments in the pathogenesis and treatment of steroid-induced osteoporosis

1 reference

12 December 2020

Trampolines are useful in the treatment of cystic fibrosis patients

1 reference

12 December 2020

Anabolic Actions of Parathyroid Hormone on Bone*

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/926045

1 reference

2 August 2017

1 reference

2 August 2017

1 reference